Q4 2023 Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results Regeneron Pharmaceuticals Q4 2023 Earnings Conference Call Regeneron February 2024 Corporate Presentation 2.2 MB Q4 2023 Earnings Conference Call Transcript 431.1 KB Form 10-K Annual Reports Date Title 2023 Annual Report 2023 Annual Report Proxy Statements Date Title 2024 Proxy Statement 2024 Proxy Statement Form 10-K Filing date View Feb 05, 2024 View HTML 0001804220-24-000009.pdf 0001804220-24-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Feb 06, 2023 View HTML 0001804220-23-000008.pdf 0001804220-23-000008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View Nov 02, 2023 View HTML 0001804220-23-000031v2.pdf 1.2 MB 0001804220-23-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Aug 03, 2023 View HTML 0001804220-23-000023v2.pdf 1.2 MB 0001804220-23-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Interactive Analyst Center Interactive and downloadable financial data for investors and analysts View Analyst Center